Compare BCBP & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCBP | TMCI |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 120.4M |
| IPO Year | 2005 | 2021 |
| Metric | BCBP | TMCI |
|---|---|---|
| Price | $9.64 | $2.52 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $10.00 | $4.77 |
| AVG Volume (30 Days) | 83.8K | ★ 447.8K |
| Earning Date | 04-21-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | $85.26 | N/A |
| Revenue Next Year | $6.14 | $8.18 |
| P/E Ratio | $37.08 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $7.31 | $1.17 |
| 52 Week High | $10.50 | $7.78 |
| Indicator | BCBP | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 72.85 |
| Support Level | $9.15 | $2.36 |
| Resistance Level | $9.87 | $3.06 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 11.92 | 95.76 |
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.